Acute basilar artery (BA) occlusion is a devastating form of posterior circulation stroke, with a high risk of long-term disability or death if recanalization is not performed early.1 Performance of emergent recanalization therapy is mainly determined by symptom onset time, stroke severity, and brain imaging. Transcranial Doppler sonography (TCD) is a non-invasive and safe technique that can provide information on the real-time hemodynamic status of recanalized vessels after reperfusion therapy in acute stroke settings, which may help to predict patient prognosis.2
Subclavian steal syndrome refers to the pathophysiological phenomenon of blood flow away from the vertebral artery ipsilateral to a hemodynamically significant stenosis or occlusion of the prevertebral subclavian artery3 . Herein, we report a case of acute BA tip thrombosis with no significant pre-BA stenosis or occlusion in which TCD showed systolic flow reversal as a subclavian-basilar steal phenomenon that led to successful endovascular thrombectomy.
CASE
The patient was a 72-year-old man who was a current 15 pack-year smoker and had been diagnosed with hypertension and dyslipidemia. His medications included candesartan 8 mg, atorvastatin 10 mg, fenofibrate 160 mg, and antiplatelet drugs including cilostazol 100 mg and aspirin 100 mg. He suddenly developed dizziness immediately after going to the bathroom in the middle of the night (onset-to-arrival time, 66 minutes). Upon arrival, his blood pressure was 140/92 mmHg and National Institutes of Health Stroke Scale (NIHSS) score was 0. Two hours and ten minutes after the onset of dizziness, he further developed dysarthria, left facial palsy, left-sided motor weakness, and subjective sensory numbness. Brain diffusion-weighted imaging performed 2 hours and 50 minutes after onset revealed faint high signal intensities in the right peripheral pons, right superior cerebellum, and right middle cerebellar peduncle (Fig. 1A, 1B, and 1C, respectively). His neurological symptoms, including left lower facial palsy and mild dysarthria, were alleviated (NIHSS 2). Brain magnetic resonance angiography (MRA) nine hours after onset showed occlusion at the BA tip, but the flow patency of both posterior cerebral arteries (PCAs) was preserved (Supplementary Fig. 1A, 1B). Notably, neck MRA revealed no stenosis or occlusion of the subclavian artery proximal to the origin of the vertebral artery (Supplementary Fig. 1C). Furthermore, the aortic arch was normal, and there was no evidence of compression of the subclavian artery (e.g., Takayasu arteritis or cervical rib). Baseline TCD demonstrated initial systolic flow reversal along the BA and left vertebral artery due to distal BA occlusion (Fig. 2A); however, his neurological symptoms remained unchanged (NIHSS 2). His blood pressure was 132/86 mmHg before TCD. Two days after symptom onset, transfemoral cerebral angiography revealed the presence of a BA tip thrombus that blocked the orifice of the right PCA; however, its distal flow was maintained through the ipsilateral posterior communicating artery (Supplementary Fig. 2A), a finding similar to that of the previous MRA. The thrombus was retrieved in one attempt with suction thrombectomy by an interventional neurologist, and the BA tip was recanalized using TICI (thrombolysis in cerebral infarction) 2b (Supplementary Fig. 2B). His neurological symptoms gradually disappeared, and follow-up TCD one day after thrombectomy showed retrograde systolic flow at the proximal BA with a low-amplitude (weak flow) waveform at the distal BA, suggesting partial improvement in flow (Fig. 2B). Follow-up TCD performed 4 days after the thrombectomy revealed a near-normal flow pattern and direction along the vertebrobasilar track (Fig. 2C). His blood pressure was 137/82 mm Hg prior to the follow-up TCD study. Further serial follow-up TCD could not be performed because of the cost burden. The embolic source of the stroke remained undetermined despite a full cardioembolic workup. Secondary stroke prevention was managed with antiplatelet drugs (clopidogrel 75 mg and aspirin 100 mg for four weeks, followed by clopidogrel 75 mg thereafter) and high-dose statin. Three months later, the patient was neurologically free of symptoms, and follow-up brain MRA showed complete recanalization of the BA tip (Supplementary Fig. 2C); however, T2-weighted imaging revealed focal high intensity in the crus cerebri of the right lower midbrain due to previous BA tip occlusion (Fig. not shown).
DISCUSSION
Subclavian artery steal is asymptomatic in most patients. In patients with flow reversal of the vertebral artery ipsilateral to a subclavian stenosis/occlusion, 76% had antegrade flow in the BA.4 Patients with antegrade flow in the BA are less likely to experience neurological symptoms;4 however, our patients had minor and stationary neurological symptom despite the retrograde systolic flow in the BA on TCD.
We acknowledge that our patient did not comply with the protocol for acute stroke management, notwithstanding the patient’s visit within the golden time. His neurological symptoms were minor (left facial palsy and dysarthria according to the NIHSS 2), and deciding on endovascular treatment was challenging due to the discrepancy between the initial occlusion at the BA tip and minor neurological symptoms. However, TCD findings of retrograde flow from the BA provided critical information regarding the likelihood of a high risk of neurological deterioration, encouraging prompt endovascular treatment.
In this case, it remains unclear why the retrograde systolic flow along the vertebrobasilar track recovered slowly despite successful recanalization. Notably, TCD after thrombectomy (Fig. 2B) demonstrated a paucity of retrograde flow in the BA at depths of 94 and 100 mm, in contrast to the findings from the BA at depths of 80 90 mm. This phenomenon could be ascribed to the low blood volume reaching the distal BA owing to retrograde flow below the mid-BA level. The waveform in the distal BA showed a blunting pattern, suggesting weak flow. The temporal discrepancy is speculated to be ascribed to remodeling from an invisible residual thrombus between the clinical improvement following reperfusion therapy and the normalized time point of TCD. Nevertheless, the degree of flow reversal showed a sequential decrease, and our patient showed no fluctuations in blood pressure or newly developed neurological symptoms after mechanical thrombectomy.
TCD is a feasible, and valid non-invasive bedside method for evaluating the cerebral hemodynamics in acute stroke setting.5 The systolic flow reversal along the vertebrobasilar track was an acutely developing finding, which is distinct from largely asymptomatic chronic subclavian steal syndrome. This was a unique case of posterior circulation stroke demonstrating a subclavian-basilar steal phenomenon on real-time TCD without prevertebral subclavian artery stenosis. Given that acute BA occlusion is known to be a high-risk factor for grave stroke and clinicoradiological dissociation as a minor neurological symptom with large vessel occlusion delaying timely treatment, TCD is suggested to play a critical role in identifying hemodynamic insufficiency and determining the implementation of endovascular intervention to mitigate stroke progression.